JAGX stock: buy or sell?

JAGX stock price: $1.44 2.13% At close on September 20th, 2019

Updated on:
September 20th, 2019

1

Jaguar Health shares rose 2.13% to $1.44 today. On Tuesday JAGX climbed a dazzling 10.06%. On Sep 18th JAGX plunged a bloodcurdling -8.90%.

Jaguar Health, Inc., a commercial stage natural-products pharmaceuticals company, focuses on developing novel, sustainably derived gastrointestinal products for human prescription use and animals worldwide.

Should I buy JAGX stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Jaguar Health stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Jaguar Health stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we detected 2 ratings published for JAGX stock in the last 30 days.

Is JAGX a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-12LADENBURG THALM/SH SHn/aBuy
2019-7-2HC Wainwrightn/aBuy

JAGX stock analysis

Daily outlook

Jaguar Health ended today at $1.44 and rose a remarkable 2.13%.

Shares of Jaguar Health ended today at $1.44 and rose a remarkable 2.13%.

JAGX stock chart (daily)

Weekly outlook

Jaguar Health shares skyrocketed 8.27% this week, ending at $1.44. By mid August JAGX plummed a dreadful -38.74% in just one week.

Observing the weekly chart, price is in a simple uptrend, tested $1.05 level and now climbing back aiming its last top at $1.56. Since price and 20-weeks moving average lines crossed down early April, JAGX fell $-20.68 per share (-93.49%).

JAGX stock chart (weekly)

JAGX stock price history

JAGX stock went public on June 9th, 2016 with a price of $2,940.001. Since then, JAGX stock lost a -100.00%, with a yearly average of -33.30%.

1: Adjusted price after possible price splits or reverse-splits.

JAGX stock historical price chart

JAGX stock reached 52-week highs at $175.00, and all-time highs 2016-06-09 with a price of 3979.5.

JAGX stock price target is $10.00

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. Currently, only 1 price forecast for Jaguar Health stock was posted in the last 30 days:
JAGX stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-7-2HC WainwrightSet Price Targetn/a$10.00-
(in average)$0.00$10.000.0%

Financials and fundamental analysis

Earnings date and Earnings per Share

Since April, when Jaguar Health published its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will extend this review.
JAGX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.32n/a
2017-Q2-n/a-0.12n/a
2017-Q32017-11-14-0.13-0.06n/a
2017-Q42018-04-04n/an/an/a
2018-Q12018-05-15n/a-0.05n/a
2018-Q22018-08-13n/a-0.76n/a
2018-Q32018-11-19n/a-0.61n/a
2018-Q42019-04-01n/an/an/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Jaguar Health annual turnover gained a tiny 1.26% to $4.42 million USD from $4.36 marked in 2017. Nevertheless, its income margin (compared to sales) plunged to -727.92%, that is $-32.15 million.

JAGX annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2015$0.26 M-$-16.29 M-6305.2%-
2016$0.14 M-45.23%$-14.73 M-10410.9%-9.56%
2017$4.36 M2,981.61%$-21.97 M-503.7%49.10%
2018$4.42 M1.26%$-32.15 M-727.9%46.33%

Quarterly financial results

Jaguar Health posted $1.60 M in revenues for 2018-Q4, a 40.97% improvement compared to previous quarter. Reported quarter earnings marked $-12.65 million with a profit margin of -792.91%. Profit margin collapsed a -250.69% compared to previous quarter when profit margin was -542.22%. When comparing sales to same quarter last year, Jaguar Health sales marked a fine gain and appreciated a 3.49%. Looking back to recent quarterly results, Jaguar Health posted 3 negative quarters in a row.
JAGX quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$0.82 M-$-4.72 M-573.9%-
2017-Q2$0.90 M9.01%$-1.81 M-201.9%-61.65%
2017-Q3$1.10 M22.72%$4.76 M432.6%-362.97%
2017-Q4$1.54 M40.16%$-20.21 M-1310.4%-524.54%
2018-Q1$0.80 M-47.84%$-5.70 M-708.2%-71.81%
2018-Q2$0.88 M9.88%$-7.66 M-866.3%34.42%
2018-Q3$1.13 M28.08%$-6.14 M-542.2%-19.84%
2018-Q4$1.60 M40.97%$-12.65 M-792.9%106.14%

Jaguar Health ownership

When you are planning to buy a stock, it's always worth to overview its ownership structure.

Jaguar Health shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 13.23% of all shares.

In case of Jaguar Health stock, 13.20% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for JAGX stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related companies:

JAGX
Market cap$8.7 M
Total shares6.1 M
Float shares5.5 M
  - Institutional holdings (%)13.2%
  - Insider holdings (%)13.2%
Shares in short selling0.0%

JAGX summary

Friday, September 20th, 2019
Open$1.38
Close$1.44
Day range$1.31 - $1.45
Previous close$1.41
Session gain2.13%
Average true range$0.13
50d mov avg$1.56
100d mov avg$5.37
200d mov avg$11.71
Daily pattern
Weekly pattern lb01a

Jaguar Health performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Jaguar Health against in the following table:
Stock3m6m12m
JAGXJaguar Health-69.30%-93.82%-96.84%

Jaguar Health competitors

Unfortunately, we could not find any public company that could be defined as Jaguar Health competitor. This doesn't mean Jaguar Health does not have any competitor in the market, it's just we could not detected it.